Steven Lichtman
Stock Analyst at Oppenheimer
(4.53)
# 386
Out of 4,479 analysts
46
Total ratings
56.25%
Success rate
28.63%
Average return
Main Sectors:
Top Industries:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Outperform | $47 → $58 | $39.15 | +48.15% | 1 | Jun 10, 2024 | |
| ALC Alcon | Upgrades: Outperform | $103 | $88.79 | +16.00% | 2 | May 15, 2024 | |
| BWAY BrainsWay | Maintains: Outperform | $10 → $11 | $5.92 | +85.81% | 4 | May 9, 2024 | |
| RXST RxSight | Maintains: Outperform | $61 → $72 | $57.04 | +26.23% | 7 | May 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $150 → $155 | $106.27 | +45.85% | 4 | May 3, 2024 | |
| ANGO AngioDynamics | Upgrades: Outperform | $12 | $5.66 | +112.01% | 2 | Apr 5, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $82 → $87 | $86.50 | +0.58% | 1 | Feb 29, 2024 | |
| MDT Medtronic | Maintains: Perform | $89 → $92 | $77.37 | +18.91% | 6 | Feb 21, 2024 | |
| BSX Boston Scientific | Maintains: Perform | $58 → $68 | $76.55 | -11.17% | 2 | Feb 1, 2024 | |
| MODD Modular Medical | Reiterates: Outperform | $3.5 | $1.54 | +127.27% | 2 | Sep 19, 2023 | |
| PODD Insulet | Upgrades: Outperform | $300 → $275 | $197.19 | +39.46% | 2 | Jan 31, 2022 | |
| DXCM DexCom | Maintains: Outperform | n/a | $112.49 | - | 3 | Jul 30, 2021 | |
| SYK Stryker | Maintains: Perform | n/a | $334.30 | - | 1 | Jul 28, 2021 | |
| GKOS Glaukos | Downgrades: Perform | n/a | $118.98 | - | 3 | Jul 14, 2021 | |
| STAA STAAR Surgical Company | Initiates: Perform | n/a | $44.52 | - | 1 | Jul 9, 2021 | |
| COO The Cooper Companies | Maintains: Perform | $83 → $85 | $86.51 | -1.75% | 3 | Sep 4, 2020 | |
| MNKD MannKind | Initiates: Outperform | n/a | $5.03 | - | 1 | Dec 24, 2019 | |
| AVGR Avinger | Downgrades: Perform | n/a | $1.79 | - | 1 | Apr 12, 2017 |
Tandem Diabetes Care
Jun 10, 2024
Maintains: Outperform
Price Target: $47 → $58
Current: $39.15
Upside: +48.15%
Alcon
May 15, 2024
Upgrades: Outperform
Price Target: $103
Current: $88.79
Upside: +16.00%
BrainsWay
May 9, 2024
Maintains: Outperform
Price Target: $10 → $11
Current: $5.92
Upside: +85.81%
RxSight
May 7, 2024
Maintains: Outperform
Price Target: $61 → $72
Current: $57.04
Upside: +26.23%
Zimmer Biomet Holdings
May 3, 2024
Maintains: Outperform
Price Target: $150 → $155
Current: $106.27
Upside: +45.85%
AngioDynamics
Apr 5, 2024
Upgrades: Outperform
Price Target: $12
Current: $5.66
Upside: +112.01%
Merit Medical Systems
Feb 29, 2024
Maintains: Outperform
Price Target: $82 → $87
Current: $86.50
Upside: +0.58%
Medtronic
Feb 21, 2024
Maintains: Perform
Price Target: $89 → $92
Current: $77.37
Upside: +18.91%
Boston Scientific
Feb 1, 2024
Maintains: Perform
Price Target: $58 → $68
Current: $76.55
Upside: -11.17%
Modular Medical
Sep 19, 2023
Reiterates: Outperform
Price Target: $3.5
Current: $1.54
Upside: +127.27%
Insulet
Jan 31, 2022
Upgrades: Outperform
Price Target: $300 → $275
Current: $197.19
Upside: +39.46%
DexCom
Jul 30, 2021
Maintains: Outperform
Price Target: n/a
Current: $112.49
Upside: -
Stryker
Jul 28, 2021
Maintains: Perform
Price Target: n/a
Current: $334.30
Upside: -
Glaukos
Jul 14, 2021
Downgrades: Perform
Price Target: n/a
Current: $118.98
Upside: -
STAAR Surgical Company
Jul 9, 2021
Initiates: Perform
Price Target: n/a
Current: $44.52
Upside: -
The Cooper Companies
Sep 4, 2020
Maintains: Perform
Price Target: $83 → $85
Current: $86.51
Upside: -1.75%
MannKind
Dec 24, 2019
Initiates: Outperform
Price Target: n/a
Current: $5.03
Upside: -
Avinger
Apr 12, 2017
Downgrades: Perform
Price Target: n/a
Current: $1.79
Upside: -